DLG4 and early-onset autosomal dominant Alzheimer disease: FMT can improve cognitive function by decreasing the accumulation of amyloid b and upregulating the expression of synaptic markers (PSD-95, synaptophysin-1) in Alzheimer’s disease (Hediyal et al., 2024).